ClinVar Miner

Submissions for variant NM_000179.3(MSH6):c.3957_3958dup (p.Ala1320fs)

dbSNP: rs2530875238
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002357639 SCV002619496 likely pathogenic Hereditary cancer-predisposing syndrome 2020-07-30 criteria provided, single submitter clinical testing The c.3957_3958dupAG variant, located in coding exon 9 of the MSH6 gene, results from a duplication of AG at nucleotide position 3957, causing a translational frameshift with a predicted alternate stop codon (p.A1320Efs*8). This alteration occurs at the 3' terminus of theMSH6 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 41 amino acids of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function based on an internal structural analysis indicating this variant disrupts a portion of the MSH2-MSH6 binding site in a region where pathogenic variants have been observed (Ambry internal data; Warren JJ et al. Mol. Cell, 2007 May;26:579-92). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.